353 related articles for article (PubMed ID: 18342518)
1. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of isogranulatimide analogues.
Hugon B; Anizon F; Bailly C; Golsteyn RM; Pierré A; Léonce S; Hickman J; Pfeiffer B; Prudhomme M
Bioorg Med Chem; 2007 Sep; 15(17):5965-80. PubMed ID: 17582773
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
Conchon E; Anizon F; Aboab B; Prudhomme M
J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents.
Pierce LT; Cahill MM; Winfield HJ; McCarthy FO
Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.
Sako Y; Ichikawa S; Osada A; Matsuda A
Bioorg Med Chem; 2010 Nov; 18(22):7878-89. PubMed ID: 20943405
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents.
Routier S; Peixoto P; Mérour JY; Coudert G; Dias N; Bailly C; Pierré A; Léonce S; Caignard DH
J Med Chem; 2005 Mar; 48(5):1401-13. PubMed ID: 15743184
[TBL] [Abstract][Full Text] [Related]
11. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.
Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C
J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100
[TBL] [Abstract][Full Text] [Related]
12. Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors.
Hénon H; Messaoudi S; Anizon F; Aboab B; Kucharczyk N; Léonce S; Golsteyn RM; Pfeiffer B; Prudhomme M
Eur J Pharmacol; 2007 Jan; 554(2-3):106-12. PubMed ID: 17134696
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of pyrrolo[3,4-a]carbazole-1,3-diones, pyrrolo[3,4-c]carbazole-1,3-diones, and 2-aminopyridazino[3,4-a]pyrrolo[3,4-c]carbazole-1,3,4,7-tetraone.
Conchon E; Anizon F; Aboab B; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
Eur J Med Chem; 2008 Feb; 43(2):282-92. PubMed ID: 17502122
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
Sathiyachandran P; Manogaran P; Nesterov VN; Padma VV; Rajendra Prasad KJ
Eur J Med Chem; 2018 Apr; 150():851-863. PubMed ID: 29597168
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicities of 7-aza rebeccamycin analogues bearing various substituents on the sugar moiety, on the imide nitrogen and on the carbazole framework.
Messaoudi S; Anizon F; Léonce S; Pierré A; Pfeiffer B; Prudhomme M
Eur J Med Chem; 2005 Oct; 40(10):961-71. PubMed ID: 15907347
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.
Baltus CB; Jorda R; Marot C; Berka K; Bazgier V; Kryštof V; Prié G; Viaud-Massuard MC
Eur J Med Chem; 2016 Jan; 108():701-719. PubMed ID: 26741853
[TBL] [Abstract][Full Text] [Related]
19. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
20. Regio- and stereoselective synthesis of dispirooxindole-pyrrolocarbazole hybrids via 1,3-dipolar cycloaddition reactions: Cytotoxic activity and SAR studies.
Murali K; Sparkes HA; Rajendra Prasad KJ
Eur J Med Chem; 2018 Jan; 143():292-305. PubMed ID: 29197734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
